Selegiline in treatment of behavioral and cognitive symptoms of Alzheimer disease

Annals of Pharmacotherapy

Volumn 30, Issue 10, 1996, Pages 1122-1129

  Tolbert, S R ^a   Fuller, M A ^a  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOAMINE OXIDASE INHIBITOR; SELEGILINE;

ALZHEIMER DISEASE; BEHAVIOR DISORDER; CLINICAL TRIAL; COGNITIVE DEFECT; DRUG EFFECT; DRUG EFFICACY; GASTROINTESTINAL SYMPTOM; HUMAN; META ANALYSIS; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY;

EID: 0029743744     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809603001012     Document Type: Review

References (0)